Proteomic Analysis on Multi-Drug Resistant Cells HL-60/DOX of Acute Myeloblastic Leukemia

Chun-Yan Chen ； Ji-Hui Jia ； Mao-Xiu Zhang ； Yue-Sheng Meng ； De-Xiao Kong ； Xiang-Lin Pan ； Xiu-Ping Yu

《The Chinese Journal of Physiology》 48卷3期 (2005/09) Pp. 115-120

摘要

無資料

關鍵字

leukemia ； myeloblastic ； multi-drug resistance ； proteomics

並列摘要

Multi-drug resistance (MDR) is an important factor that causes treatment failure in acute leukemia. However, the full development mechanisms of MDR still awaits investigation. The purpose of this study is to investigate differentially expressed proteins in the multi-drug resistant acute myeloblastic leukemia (AML) cell line HL-60/DOX and the drug sensitive cell line HL-60, and to identify new potential multi-drug resistant related molecules with the proteomic approach. Two-dimensional gel electrophoresis (2-DE) maps of the proteins, extracted from two AML cell lines, HL-60/DOX and HL60, were established respectively. The extracted proteins were digested by enzymes and identified with the matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The data of the peptide mass fingerprinting (PMF) was matched with databases of proteomics available on the Internet. Results showed that 16 proteins were identified to be differentially expressed between HL-60/DOX and HL-60 cells. They involved the protein disulfide isomerase precursor (PDI), the proteasomes α1 and other proteins which are related to drug resistance or cell metabolism, but their functional significances are required further investigation. Nevertheless, it is clear that this proteomic approach for studing the biology and development of MDR is a prerequisite in leukemia.

參考文獻

Gong, Y.P.,Liu, T.,Jia, Y.Q.,Qin, L.,Deng, C.Q.,Yang, R.Y.(2002).Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines.Int. J. Hematol.75,154-160.

Baker, E.K.,EI-Ota. A.(2003).The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.Exp. Cell Res..290,177-194.

Chen. G.,Gharib, T.G.,Huang, C.C.,Thomas, D.G.,Shedden, K.A.,Taylor, J.M.,Kardia, S.L.,Misek, D.E.,Giordano, T.J.,Iannettoni, M.D.,Orringer, M.B.,Hanash, S.M.,Beer, D.G.(2002).Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.Clin. Cancer Res..8,2298-2305.

Cress, A.E.,Dalton, W.S.(1996).Multiple drug resistance and intermediate filaments.Cancer Metast. Rev..15,499-506.

Fanelli, M.,Minucci, S.,Gelmetti, V.,Nervi, C.,Gambacorti-Passerini, C.,Pelicci, P.G.(1999).Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance.Blood.93,1477-1481.